Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort. - Keane F; O'Connor C; Moss D; Chou JF; Perry MA; Crowley F; Saxena P; Chan A; Schoenfeld JD; Singhal A; Park W; Cowzer D; et al. (Journal of the National Cancer Institute, 2025)